Abstract: Longitudinal data in biomedical studies often involve concomitant interventions in addition to the pre-specified repeatedly measured outcome and covariate variables. Since a concomitant intervention is often initiated when a patient exhibits an undesirable health trend, adequate statistical methods should properly incorporate the starting time of a concomitant intervention in order to reduce the potential bias of the estimated intervention effects. We propose in this paper a class of semiparametric random-effects conditional density models for evaluating the distributions and concomitant intervention effects with longitudinal observations. These models simultaneously incorporate concomitant intervention effects and intra-subject longitudinal dependence structures, and quantify the change of the distribution functions through the ratio of two conditional density functions.
Introduction
In longitudinal clinical trials and epidemiological studies, patients or study participants are repeatedly observed over time, and concomitant interventions are often given to patients, due to ethical reasons, who exhibit undesirable trends of health status during the study period. A main objective in such longitudinal studies is to evaluate the temporal trends of some health outcomes and the effects of certain covariates of interest, such as the study subjects' baseline characteristics and some pre-specified treatments, on the distributions of these health outcomes. Well-known regression methods for longitudinal analysis, including various types of parametric and nonparametric models proposed in the literature, for example, Verbeke and Molenberghs (2000) , Diggle et al. (2002) and Fitzmaurice et al. (2009), have focused on the estimation and inferences of the effects of covariates which do not depend on the outcome variables. These regression methods, however, may lead to misspecified models and biased estimates of the concomitant intervention effects because the initiation of concomitant interventions could depend on the study subject's temporal trends of the response variable.
The Enhancing Recovery in Coronary Heart Disease (ENRICHD) study is a typical example of longitudinal clinical trials, which involves a concomitant intervention in addition to the randomly assigned treatment regimens and other covariates whose values do not depend on the outcome variables.
The primary objective of this randomized clinical trial is to evaluate the efficacy of a 6-month cognitive behavior therapy (CBT) versus the usual cardiovascular care (UC) on overall mortality, cardiovascular events and depression severity in patients with depression or low perceived social support after acute myocardial infarction, where depression severity was measured by the Hamilton Rating Scale for Depression (HRSD) and the Beck Depression Inventory (BDI) with higher HRSD and BDI scores indicating worsened depression. In addition to the randomized CBT treatment, patients who had high baseline depression scores or nondecreasing BDI trends were eligible for pharmacotherapy with antidepressants as a concomitant intervention, and antidepressants were also prescribed at the requests of the patients or their primary-care physicians. Major findings of the trial and justifications of its design can be found in ENRICHD (2001, 2003) . Taylor et al. (2005) investigated the effects of pharmacotherapy on cardiovascular morbidity and mortality among 1834 depressed ENRICHD patients, and found that pharmacotherapy improved survival for this patient population.
In order to evaluate the effects of pharmacotherapy on depression severity measured by the BDI scores, Wu, Tian and Bang (2008) showed that the mixed-effects models without taking the antidepressant starting time into account led to biased estimates of pharmacotherapy effects, and these authors proposed a varying-coefficient model using the data from patients who started pharmacotherapy during the 6-month treatment period to show the beneficial effects of pharmacotherapy for lowering the patients' BDI scores.
A major drawback of the varying-coefficient model of Wu, Tian and Bang (2008) is that it does not use the data from patients who have already received pharmacotherapy at baseline or have not received pharmacotherapy during the study. As an extension based on the framework of sharedparameter models (e.g., Follmann and Wu, 1995) , Wu, Tian and Jiang (2011) proposed a change-point shared-parameter model for evaluating the concomitant intervention effects which was capable to incorporate the information from all the patients in the study. However, the method of Wu, Tian and Jiang (2011) is limited to modeling the conditional means of the outcome variables before and after the concomitant intervention through some known parametric distribution functions and estimating the parameters through a computationally intensive maximum likelihood procedure.
Xing and Ying (2012) studied a semiparametric change-point regression model based on a counting process formulation, but their regression model, which assumes environmental change-points with unknown number and locations, differs from the setup of subject-specific concomitant interventions.
We develop in this paper a class of semiparametric random-effects conditional density (RECD) models for evaluating the conditional distributions of the outcome variable and the concomitant intervention effects in a longitudinal study. By quantifying the distribution functions of the outcome variable before and after the concomitant intervention through some random-effects, our models assume that the ratio of the conditional density functions of the subject's time-dependent outcome variable has a known form specified by some unknown parameters, while the underlying baseline density remains nonparametric. This modeling framework has the attractive feature that it simultaneously incorporates the intra-subject longitudinal dependence structure and the concomitant intervention effects. Because our RECD models do not require the conditional distributions to be completely specified by a parametric family, they can be applied to studies with patients who may or may not receive concomitant interventions durStatistica Sinica: Newly accepted Paper (accepted version subject to English editing) Tianqing Liu, Colin O. Wu, Zhaohai Li and Yuanzhang Li ing the study. We develop a conditional-likelihood based estimation method for parameter estimation and inferences and an information matrix based goodness-of-fit test statistic for testing the validity of the RECD models.
Our application to the ENRICHD pharmacotherapy data and simulation results suggest that the proposed method leads to adequate parameter estimates with longitudinal data when a concomitant intervention is present.
Random-Effects Conditional Distribution Models
We introduce a general framework for longitudinal data with a concomitant intervention and a random-effects modeling approach which can simultaneously account for concomitant intervention effects and longitudinal dependence among the observations within the same subject. Further discussions are given in Section S1 of Supplementary Materials.
Parametric Random-Effects Conditional Distribution Models
Let N be the total number of randomly selected subjects. The ith subject has (n i + 1) visits and the observation (T ij , Y ij , X i ) at the jth visit, 0 ≤ j ≤ n i , where T ij is the study time defined as the time elapsed from the beginning of the study to the jth visit, X i is a time-invariant covariate vector, and Y ij is the real-valued or discrete outcome variable. For simplicity, we assume that the study involves only one concomitant intervention, and we denote by S i ∈ [0, +∞) the ith subject's intervention starting time or change-point time and δ ij = I(T ij ≥ S i ) the intervention indicator at the jth visit. In most clinical trials, the initial visit time is set to zero, i.e., T i0 = 0. But, in general, the choice of time depends on the study objectives, and the starting time may not be zero. We further define T ij = T ij − T i0 to be the time elapsed from the baseline to the jth visit and R ij = T ij − S i to be the time elapsed from the intervention starting time to the jth visit.
A positive (or negative) value of R ij suggests that the jth visit of the ith subject is after (or before) the intervention starting time S i .
We assume throughout the paper that no subject has taken the intervention before or at the start of the study, so that S i > T i0 . This assumption is made because, in order to evaluate the designated treatment effects of a clinical trial, it is common to exclude subjects who have already taken an alternative intervention at baseline. Since not every subject changes from without intervention to intervention during the study, the ith subject's change-point time is observed if T i0 < S i ≤ T in i . If S i > T in i , the subject's change-point time is "right censored". The indicator variable for
The observed change-point times are {S 
T , and the corresponding outcome values
Since the distribution of S i may depend on {X i , T i } as well as some unobserved variables, we assume that there is a latent random vector ∆ i , which depends on
so that the conditional density of
The conditional distribution of the outcome variable Y i depends on the random variables {∆ i , X i , T i , S i } and can be constructed as follows. Let
which specifies a random-effects model for Y ij . For the sake of generality, f ij (·|·) may generally refer to the density function with respect to the Lebesgue measure when Y ij is a continuous random variable on the real line, or a probability function when Y ij is a discrete or categorical random variable. Similar to the settings in the mixed-effects models (e.g., Verbeke and Molenberghs, 2000) , we assume that, within each i = 1, . . . , N, the outcome
Let β be the unknown parameter vector of interest, which is used to characterize the time trends of Y i and the concomitant intervention effects, and let φ, ψ and ϕ be the unknown nuisance parameters, so that the con-ditional density functions are specified by f S i (·|·; β, ψ), f ∆ i (·|·; ϕ) and
,
Since (2.1) belongs to a parametric family and the change-point time S i may not be observed, the log-likelihood function F (θ) for the possibly
We can in principle estimate θ by maximizing the log-likelihood function F (θ). However, in real applications, it may be difficult to correctly specify the fully parametric model (2.1), so that more flexible statistical models and computationally feasible procedures are needed in practice.
Semiparametric Random-Effects Conditional Density Models
We propose here a class of RECD models for evaluating the conditional distributions of the outcome variable and the concomitant intervention effects in a longitudinal study. In the RECD models, the distribution functions of the outcome variable before and after the concomitant intervention are quantified through some random-effects. Moreover, the ratio of the conditional density functions of the subject's time-dependent outcome variable has a known form specified by some unknown parameters, while the underlying baseline density remains nonparametric. Our RECD models simultaneously incorporate the intra-subject longitudinal dependence structure and the concomitant intervention effects.
Using the data structure of Section 2.1 and the assumption that, within
our semiparametric random-effects conditional density (RECD) models for 
be an unknown density function depending on {∆ i , X i , T i0 , S i }. Our RECD model has the form
2)
is a known function of y,
is a pre-specified p-dimensional function of {κ i , X i , T ij , δ ij , δ ij R ij }, and the α ij 's are normalizing constants such that f ij (y|∆ i , X i , T i , S i )dy = 1. With T ij = T ij and R ij = T ij − S i , the effects of trial time and antidepressant use are determined by Z T ij β, which may be specified by the following function:
3)
3) assumes that patients with different values of κ i have possibly different intercepts β 01 and β 00 , and the antidepressant effects are described by the coefficients β 2 and β 3 . When β 00 = β 01 = β 0 for some constant β 0 , it follows from (2.3) that Z
. Different forms of γ(·) correspond to various conventionally used densities in the literature. Commonly used forms of γ(·) include γ(y) = y and γ(y) = log(y) (Anderson, 1979; Kay and Little, 1987; Qin et al., 2002) .
The log-density ratio of (2.2) for any Z ij , y 1 and y 2 is
tive. It follows from (2.4) that the likelihood ratio between the points y 1 and y 2 is modulated by the covariate Z ij through its linear combination Statistica Sinica: Newly accepted Paper (accepted version subject to English editing) Z T ij β. In particular, if γ(y) = y, Z ij is one-dimensional and the response Y ij is binary, then β has the expression
which is exactly the log odds ratio. This suggests that β of (2.4) can be viewed as a generalized log-odds ratio for a given γ(y) and an arbitrary response Y ij . For vector-valued Z ij , it follows from (2.4) that the lth component of β is the change of the log-density ratio associated with a unit increase of the lth component of Z ij , when all other components of Z ij are fixed.
Estimation and Inference Methods
We develop a conditional-likelihood method for the estimation of the parameters β and the construction of a goodness-of-fit statistic based on the corresponding information matrix to test the validity of the RECD model (2.2). Unlike the fully parametric likelihood approach, our estimation method treats the other parameters and the baseline density h i (·|·) as nuisance parameters. Existing methods and approaches for the estimation of h i (·|·) are discussed in Sections S2 and S3 of Supplementary Materials.
Conditional Likelihood Estimation Method
Following Kalbfleisch (1978) , Liang and Qin (2000) and Chan (2013) , we consider the log-conditional likelihood function defined by
where
and Z i0 = 0 p×1 . Here, (3.1) is an extension of the pairwise log-conditional likelihood (Liang and Qin, 2000; Chan, 2013 ) to the RECD model (2.2).
Letβ be the maximum conditional likelihood estimator of β, such that
Justification for (3.1) is given in Lemma 1 of Supplementary Materials.
Taking the partial derivatives of C (β) with respect to the components of β, we have the following estimating equations
where U ijk (β) = ∂ ijk (β)/∂β. The global maximizerβ of (3.2), if exists, is a solution of (3.3). Let
T be the true value of β. It then follows from Lemma 1 in Section S7 of Supplementary Materials that
Using the asymptotic derivations as in Crowder (1986) and Liang & Zeger (1986) , we have the following theorem. 
with e ⊗2 representing the matrix ee T .
Proof of Theorem 1 is given in Section S7 of Supplementary Materials.
The results of Theorem 1 can be used to make asymptotically approximate inferences for β when the RECD model (2.2) holds.
Goodness-of-Fit Tests based on Information Matrix
Using the well-known information matrix equality, White (1982) 
2) to construct an information matrix based goodness-of-fit statistic for testing the validity of the RECD model (2.2).
Since the p×p symmetric matrix K N (β * )−H N (β * ) can be estimated by the
, the test statistic can be formed using the "indicators"
which are the lower triangular elements of K N (β) − H N (β). Since, as noted in White (1982) , it is often inappropriate to base the test on all p(p + 1)/2 indicators, we construct the test statistics using a subset of the indicators, namely the "diagonal indicators", which are diagonal elements of the matrix
where l = 1, · · · , d have been reassigned appropriately. The following theorem establishes the asymptotic distribution of W N .
If the model (2.2) and the conditions C1-C8 in Section S7 of Supplementary
Materials are satisfied, then
Proof of Theorem 2 is given in Section S7 of Supplementary Materials.
Since Ψ is unknown, it has to be estimated in practice. To do so, we first estimate G bŷ
Then, a consistent estimator of Ψ under the model (2.2) is
. By Theorem 2, we can test the validity of (2.2) using the goodness-of-fit statistic
where large values of Q max indicate evidence of invalidity of (2.2). The critical values of the test statistic Q max are computed using
and multivariate integration.
Simulation Study
We consider three simulation settings to investigate the finite sample properties of the estimation and inference procedures for the RECD model 
The effects of the concomitant intervention are determined by β 2 and β 3 , where β 2 = 0.2 is the initial increase of the mean outcome values at the start of the intervention and β 3 = −0.3 is the rate of decrease in the mean outcome values as the intervention duration time increases.
We consider two estimators of β, the maximum conditional likelihood estimatorβ and the maximum likelihood estimatorβ. Here,β is computed by maximizing the likelihood function of the fully parametric model of (4.1)
and σ 2 S are nuisance parameters in this fully parametric model. In case (a),
we have ∆ i ∼ N(0, 1) and S i ∼ N(2 + 0.1∆, 0.25), so that the parametric model is correctly specified. In case (b), the data are generated from (4.1) with ∆ i ∼ Exp(1) and S i ∼ Exp(1 + 3∆ 2 ), so that the parametric model is misspecified.
The simulation was repeated 1000 times. Table 1 summarizes the biases and root mean square errors (RMSE) of the estimators, the empirical coverage probabilities (ECP) of the 95% confidence intervals (CI) for the maximum conditional likelihood estimatorβ and the empirical levels (EL) of the IMT for the model (4.1). When the fully parametric model is correctly specified, the RMSEs ofβ are slightly smaller than that ofβ. However, when the fully parametric model is misspecified,β has significantly smaller RMSEs than that ofβ. Since it is often difficult in real applications to correctly specify the distributions of S i and ∆ i , these RMSE results from Table 1 suggests thatβ should be more desirable thanβ in practice. The
ECPs of the normal approximate CIs forβ are close to the nominal level of 
Application to ENRICHD Pharmacotherapy Data
Our objective for the ENRICHD Pharmacotherapy data is to evaluate the additional effects of using antidepressants on the trends of depression severity measured by the BDI scores for the patients who received antidepressants during the six-month psychosocial treatment period. Since patients in the UC arm did not have repeatedly measured BDI scores during the 6-month treatment period, we only applied our model and method to the sub-sample of the ENRICHD patients in the CBT treatment arm, which has been studied by Wu, Tian and Jiang (2011) . Within our sample, 95 started antidepressant during the treatment period and 486 did not use antidepressants before the end of the treatment period. Our sample has 36 more patients than the sample of Wu, Tian and Jiang (2011), which included only those who attended 5 or more CBT sessions.
Let Y ij , T ij , S i and R ij = T ij − S i be the ith patient's BDI score, trial time (days/100), starting time (days/100) of antidepressant use, and antidepressant duration time (days/100), respectively, at the jth visit. For all 1 ≤ i ≤ N, T i0 = 0, T in i is the trial time at the last visit, and δ ij = I(T ij ≥ S i ) is the indicator of antidepressant use at T ij . Setting γ(y) of (2.2) to γ(y) = log(1 + y), our semiparametric conditional density model for this ENRICHD sample is
where h i (y|∆ i , S i ) is an unknown density function depending on {∆ i , S i } and α ij 's are normalizing constants such that f ij (y|∆ i , T i , S i )dy = 1. With T ij = T ij and R ij = T ij − S i , the effects of trial time and antidepressant use are determined by Z T ij β, which is specified by the following two functions:
is a more general model than (a), because ( both (a) and (b), the antidepressant effects are described by β 2 and β 3 .
When h i (·|·) is the density of a log-normal distribution, (5.1) is equiv- However, since the distribution of ∆ i is unknown, the conditional likelihood method of Section 3.1 has to be used to estimate β under (5.2), which leads to the same estimators as (5.1). Table 2 shows the maximum conditional likelihood estimators of β under (5.1) with the covariate effects (a) and (b), their corresponding 95%
CIs for β j , j = 0, 1, 2, 3, and the p-values of the Wald-type test for testing 
The overall trend can be estimated byŶ i0 =∆ 1i and Figure 1 , the estimated overall trends of BDI scores for six patients with concomitant intervention are plotted based on points (log(1 + T ij ), log(1 +Ŷ ij )), j = 0, · · · , n i . The overall decreasing trend of BDI scores represents the benefit of antidepressant use for these patients.
Conclusions and discussions
We developed in this paper a class of RECD models for evaluating the distributions and concomitant intervention effects with longitudinal data.
Under these models, the conditional density ratio is assumed to have a parametric form, while the baseline density function is nonparametric. We further proposed a likelihood-based method for estimating the parameters and a goodness-of-fit test for testing the validity of the models, and derived the consistency and asymptotic normality of the conditional likelihood estimators. We illustrated the practical values of the RECD models through a simulation study and an application to a longitudinal clinical trial for depression.
Supplementary Materials
The supplementary materials contain further discussions of the models, 
